JB
Jordan Richard Barrett
Scripps Research Institute, University of Oxford
Research areas: Medicine · Public Health, Environmental and Occupational Health · Malaria Research and Control · SARS-CoV-2 and COVID-19 Research · Immunotherapy and Immune Responses
0000-0003-0746-1945
Employment
-
Scripps Research Institute Graduate Student2024 - Present
-
University of Oxford Senior Research Assistant in Clinical Immunology2022 - 2023
-
University of Oxford Clinical Immunology Research Assistant2017 - 2021
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection Save
- Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens Save
- PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial. Save
- Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies Save
- A systematic analysis of the human immune response to Plasmodium vivax. Save
- Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5 Save
- Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype Save
- Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults. Save
- PvDBPII-Matrix M elicits polyfunctional antibodies that limit parasite growth in a challenge trial Save
- Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection Save
- Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine Save
- An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females Save
- Impact of a blood-stage vaccine on Plasmodium vivax malaria Save
- Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly Save
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses Save
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial Save
- Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation. Save
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Save
- Combinatorial Tim-3 and PD-1 activity sustains antigen-specific Th1 cell numbers during blood-stage malaria. Save
- Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding. Save